References
- Fentiman IS, Rubens RD, Hayward JL. A comparison of intravenous talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer 1986; 22: 1079–81.
- Light RW. Malignant pleural effusions. In: Light RW, ed. Pleural diseases. Philadelphia, Lea & Febiger 1990: 97-116.
- Bjermer L, Gruber A, Sue-Chu M et al. Effects of intrapleural mitoxantrone and mepacrine on malignant pleur-al effusion, a randomised study. Eur J Cancer 1995; 31A: 2203–2208.
- Malden LT, Tattersall HN. Malignant effusions. Quart J Med 1986; 58: 221–39.
- Villanueva AG, Gray AW, Shahian DM et al. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994; 49: 23–25.
- Sørensen PG, Svendsen TL, Enk B. Treatment of malig-nant pleural effusion with drainage with or without instilla-tion of talc. Eur J Respir Dis 1984; 65: 131–5.
- Sudduth CD, Sahn SA. Pleurodesis for nonmalignant pleural effusions. Recommendations. Chest 1992; 102: 1855–60.
- McAlpine LG, Hulks G, Thomson. Management of recurrent malignant pleural effusion in the United Kingdom: survey of clinical practice. Thorax 1990; 45: 699–701.
- Tattersall MHN, Boyer MJ. Management of malignant pleural effusions. Thorax 1990; 45: 81–2.
- Kessinger A, Wigton RS. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol 1987; 36: 81–3.
- Ostrowski MJ. An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavitary bleomycin. Cancer 1986; 57: 721–7.
- Robinson LA, Fleming WH, Galbraith TA. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg 1993; 55: 1115–22.
- Ruckdeschel JC, Moores D, Lee JY, et al. Intrapleural therapy for malignant pleural effusions. Chest 1991; 100: 1528–35.
- Reshad K, Inui K, Takeuchi Y, et al. Treatment of malignant pleural effusion. Chest 1985; 88: 393–7.
- Vargas FS, Milanez JRC, Filomeno LTB, et al. Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest 1994; 106: 1771–5.
- Hausheer FH, Yarbro JW. Diagnosis and treatment of malignant pleural effusion. Semin Oncol 1985; 12: 54–75.
- Musch E, Loos U, Mackes KG, et al. Intrapleural mitoxantrone in the treatment of malignant pleural effusion. In: Kreicller, Link, Aigner, eds. Advances in regional cancer therapy, Basel, Karger 1988: 184-9.
- Torsten U, Opri F, Weitzel H. Local therapy of malig-nant pleural effusion with mitoxantrone. Anticancer Drugs 1992; 3: 17–8.
- Groth G, Gatzenmeier U, Haussingen K, et al. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo. Ann Oncol 1991; 2; 213–5.
- Morales M, Exposito MC. Intrapleural mitoxantrone for the palliative treatment of malignant pleural effusions. Support Care Cancer 1995; 3: 147–9.
- Feuilhade F, Brun B, Calitchi E, et al. Efficacy and tox-icity of intrapleural mitoxantrone. Bull Cancer 1989; 76: 361–5.
- Slordal L, Andersen A, Warren DJ. A sensitive and simple high-performance liquid chromatographic method for the determination of mitoxantrone in plasma. Ther Drug Monit 1993; 15: 328–33.
- Andersen A, Warren DJ, Slordal L. Quantitation of cell-associated doxorubicin by HPLC after enzymatic dese-questration. Cancer Chemother Pharmacol 1994; 34: 197–202.
- Lych TJ, Kalish L, Mentzer SJ, Decamp MC, Strauss G, Sugarbaker D. Optimal therapy of malignant pleural effu-sions. Report of a randomized trial of bleomycin, tetracycline, and talc and a meta-analysis. Int J Oncol 1996; 8: 183–90.